PROVIDER PROFILE · NPI 1912939844
Manuela Pedra-NobreM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
280
Unique beneficiaries
—
Total services
57,241
Distinct HCPCS
8
Medicare payment
$293K
Peer benchmark
Total Medicare services vs. 179 Rheumatology providers in NJ — top quintile (cohort median 19,050).
PRESCRIBING · PART D · 2024
Total Rx claims
1,213
Beneficiaries
—
Total drug cost
$1.2M
Distinct drugs
28
Brand share
26.1%
Top prescribed drugs
Prednisone219 claims
Hydroxychloroquine Sulfate175 claims
Methotrexate Sodium146 claims
Duloxetine Hcl72 claims
Nabumetone65 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$933
Payment records
36
By payment type
Food and Beverage$833
Education$100
Top paying entities
Food and Beverage$833
Education$100
REFERRAL NETWORK
Where Manuela Pedra-Nobre's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| CRESCENDO BIOSCIENCE, INC | 34 | 49 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 21 | 39 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE